MTM Competitors and Similar CompaniesClear all
GeneCentric Therapeutics's competitors and similar companies include Bio-Path Holdings and Cambridgene.
 GeneCentric Therapeutics GeneCentric Therapeutics is a company providing technology to identify drug responder populations that enable the development of precision cancer drugs. |  Bio-Path Holdings Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company. |  Cambridgene Cambridgene (also known as Svastia) is a company that specializes in clinical studies, biomarker discovery, and patient stratification strategies. | |
Founding Date | Founding Date 2011 | Founding Date 2007 | Founding Date 2014 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Durham, US HQ | Locations Bellaire, US HQ | Locations Cambridge, GB HQ San Francisco, US |
Employees | Employees 12 | Employees 913% increase | Employees 3 |
Funding | |||
Total funding raised | Total funding raised $ 6.1m | Total funding raised $ 2.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Bio-Path Holdings
HQ
Bellaire, US
Employees
9↑ 13% increase
Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.
View companyCambridgene
HQ
Cambridge, GB
Employees
3
Cambridgene (also known as Svastia) is a company that specializes in clinical studies, biomarker discovery, and patient stratification strategies.
View company